DataDrivenInvestor December 6, 2023
Flavio Aliberti

Explore Big Pharma’s M&A trends, their impact on supply chains, and the urgent need for adaptability in a rapidly evolving healthcare landscape However, researching partnerships, acquisitions, and divestments made by large multinational firms over time reveals trends and evolutionary patterns in the ecosystem. In this article, I will consider some mergers and acquisitions...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Supply Chain, Technology, Trends
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
PBMs push private-label biosimilars in 2025 formularies
CAR T-Cell Pioneer Plots Technology’s Next Steps
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
GLP-1 drug use for weight loss has soared, costing billions

Share This Article